Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors. Annals of the rheumatic diseases. p. 941. [Online].